| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
218,850,000 |
| Market
Cap: |
39.94(B) |
| Last
Volume: |
90,505,923 |
Avg
Vol: |
10,707,238 |
| 52
Week Range: |
$182.5 - $182.5 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Goff Brian |
EVP & Chief Commercial Officer |
• – – |
2017-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
14,719 |
14,719 |
|
- |
|
| Orloff John J |
EVP, Research & Development |
• – – |
2017-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
24,965 |
24,965 |
|
- |
|
| Brennan David R |
Director |
– • – |
2017-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,030 |
4,833 |
|
- |
|
| Baker Brothers Life Sciences Lp |
Director |
– • – |
2017-05-10 |
4 |
A |
$0.00 |
$0 |
I/I |
4,060 |
6,106,592 |
|
- |
|
| Mollen John T |
Director |
– • – |
2017-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,030 |
4,333 |
|
- |
|
| Norby R Douglas |
Director |
– • – |
2017-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,030 |
4,906 |
|
- |
|
| Coughlin Christopher J |
Director |
– • – |
2017-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,030 |
4,333 |
|
- |
|
| Veneman Ann M |
Director |
– • – |
2017-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,030 |
7,015 |
|
- |
|
| Parven Alvin S |
Director |
– • – |
2017-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,030 |
8,403 |
|
- |
|
| Burns M Michele |
Director |
– • – |
2017-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,030 |
4,353 |
|
- |
|
| Rummelt Andreas |
Director |
– • – |
2017-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,030 |
17,246 |
|
- |
|
| Hantson Ludwig |
CEO |
• • – |
2017-03-29 |
4 |
A |
$0.00 |
$0 |
D/D |
28,725 |
57,450 |
|
- |
|
| Oneill Julie |
EVP. Global Operations |
• – – |
2017-03-02 |
4 |
S |
$133.80 |
$87,104 |
D/D |
(651) |
37,864 |
|
- |
|
| Moriarty John B |
EVP & General Counsel |
• – – |
2017-03-01 |
4 |
S |
$132.50 |
$37,365 |
D/D |
(282) |
44,672 |
|
- |
|
| Mackay Martin |
EVP & Global Head of R&D |
• – – |
2017-03-01 |
4 |
S |
$132.50 |
$49,025 |
D/D |
(370) |
50,688 |
|
- |
|
| Wagner Heidi L |
SVP, Global Government Affairs |
• – – |
2017-03-01 |
4 |
S |
$132.50 |
$20,670 |
D/D |
(156) |
29,010 |
|
- |
|
| Carmichael Clare |
EVP, Chief HR Officer |
• – – |
2017-03-01 |
4 |
S |
$132.50 |
$53,530 |
D/D |
(404) |
39,161 |
|
- |
|
| Bell Leonard |
Director |
– • – |
2017-03-01 |
4 |
S |
$132.50 |
$164,300 |
D/D |
(1,240) |
390,670 |
|
- |
|
| Thiel Carsten |
EVP, Chief Commercial Officer |
• – – |
2017-02-28 |
4 |
AS |
$131.01 |
$495,611 |
D/D |
(3,783) |
33,860 |
|
- |
|
| Miller Edward |
SVP, Chief Compliance Officer |
• – – |
2017-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,400 |
19,284 |
|
- |
|
| Miller Edward |
SVP, Chief Compliance Officer |
• – – |
2017-02-28 |
4 |
S |
$131.70 |
$43,461 |
D/D |
(330) |
14,884 |
|
- |
|
| Moriarty John B |
EVP & General Counsel |
• – – |
2017-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
51,172 |
|
- |
|
| Moriarty John B |
EVP & General Counsel |
• – – |
2017-02-28 |
4 |
S |
$131.71 |
$119,856 |
D/D |
(910) |
44,954 |
|
- |
|
| Oneill Julie |
EVP. Global Operations |
• – – |
2017-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
38,515 |
|
- |
|
| Oneill Julie |
EVP. Global Operations |
• – – |
2017-02-28 |
4 |
S |
$131.70 |
$87,449 |
D/D |
(664) |
31,015 |
|
- |
|
1501 Records found
|
|
Page 10 of 61 |
|
|
